Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/65995
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDannlowski, U.en
dc.contributor.authorBaune, B.en
dc.contributor.authorBockermann, I.en
dc.contributor.authorDomschke, K.en
dc.contributor.authorEvers, S.en
dc.contributor.authorArolt, V.en
dc.contributor.authorHetzel, G.en
dc.contributor.authorRothermundt, M.en
dc.date.issued2008en
dc.identifier.citationHuman Psychopharmacology-Clinical and Experimental, 2008; 23(7):587-593en
dc.identifier.issn0885-6222en
dc.identifier.issn1099-1077en
dc.identifier.urihttp://hdl.handle.net/2440/65995-
dc.description.abstractOBJECTIVES: To investigate the adjunctive effects of quetiapine on overall treatment response and on specific symptoms in agitated depression. METHODS: Twenty-one patients suffering from an acute agitated major depressive episode were enrolled in the quetiapine/venlafaxine study group (QUET) in the context of a 6-week open-label, flexible dose, non-randomized case-control study. Eighteen matched depressed patients treated with antidepressants only served as controls (CON). Clinical assessment was carried out by the use of Hamilton Rating Scale for Depression (HAM-D) 21 scale. RESULTS: Both groups had high HAM-D scores at baseline (27.6 vs. 27.5; p = 0.94). The QUET group displayed a significantly larger HAM-D decrease already after 1 week of treatment (p = 0.026, d = 0.77). This group difference increased slightly until week 6 (p = 0.005, d = 1.0). The remission rate in the QUET group (70%) was almost double that of the CON group (38.5%), p = 0.022. The overall effect originated from various HAM-D items indicating agitation, sleep problems and anxiety. CONCLUSIONS: Adjunctive quetiapine treatment in agitated depression showed faster and greater response leading to higher remission rates compared with antidepressants alone. Overall clinical improvement was specifically related to single aspects of psychopathology indicating that quetiapine develops its positive effects through a variety of psychopharmacological properties.en
dc.description.statementofresponsibilityUdo Dannlowski, Bernhard T. Baune, Iris Böckermann, Katharina Domschke, Stefan Evers, Volker Arolt, Günter Hetzel and Matthias Rothermundten
dc.language.isoenen
dc.publisherJohn Wiley & Sons Ltden
dc.rightsCopyright © 2008 John Wiley & Sons, Ltd.en
dc.subjectquetiapine; agitation; major depression; sleep; adjunctive treatmenten
dc.titleAdjunctive antidepressant treatment with quetiapine in agitated depression: positive effects on symptom reduction, psychopathology and remission ratesen
dc.typeJournal articleen
dc.identifier.rmid0020111400en
dc.identifier.doi10.1002/hup.963en
dc.identifier.pubid28333-
pubs.library.collectionPsychiatry publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidBaune, B. [0000-0001-6548-426X]en
Appears in Collections:Psychiatry publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.